Riddle Valerie D 4
4 · PHARMATHENE, INC · Filed Jun 1, 2011
Insider Transaction Report
Form 4
Riddle Valerie D
VP, Medical Director
Transactions
- Sale
Common Stock, $0.0001 par value per share
2011-05-31$4.00/sh−3,438$13,752→ 49,790 total - Exercise/Conversion
Option to purchase
2011-05-31−3,438→ 20,627 totalExercise: $2.46Exp: 2019-01-21→ Common Stock (3,438 underlying) - Sale
Common Stock, $0.0001 par value per share
2011-05-25$3.75/sh−4,775$17,906→ 49,790 total - Exercise/Conversion
Option to purchase
2011-05-25−4,775→ 14,317 totalExercise: $2.96Exp: 2013-10-14→ Common Stock (4,775 underlying) - Sale
Common Stock, $0.0001 par value per share
2011-05-31$4.01/sh−5,354$21,470→ 44,436 total - Exercise/Conversion
Common Stock, $0.0001 par value per share
2011-05-25$2.96/sh+4,775$14,134→ 54,565 total - Exercise/Conversion
Common Stock, $0.0001 par value per share
2011-05-31$2.46/sh+3,438$8,457→ 53,228 total
Footnotes (3)
- [F1]The transactions reported hereon have been effected pursuant to the Reporting Person's 10b5-1 Plan.
- [F2]The option exercised is part of a October 14, 2003 grant of options to purchase an aggregate of 19,092 shares, which is fully vested.
- [F3]The option exercised is part of a January 21, 2009 grant of options to purchase an aggregate of 27,503 shares, which vests over a 4 year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.